Bioventus Inc.
A maker of orthobiologic therapies that help the body heal itself, Bioventus Inc. sells the EXOGEN ultrasound bone-healing system and Durolane joint injections for osteoarthritis, giving patients non-surgical options for orthopedic care. Founded in 2012 in Durham, North Carolina, the company was spun out of medical-technology firm Smith & Nephew. Its name blends the Greek word for life with the Latin for wind — fittingly, EXOGEN itself began as a separate company before joining the lineup.
Granted 89.2K
Granted 104.3K · Bought 105.5K
Granted 96.7K
Granted 252.9K · Sold 59.1K
Granted 165.5K · Sold 39.2K
Granted 89.2K · Sold 10.0K
Granted 89.2K
Granted 221.0K · Sold 28.8K
Granted 89.2K
Granted 91.0K
Granted 90.1K
Granted 89.6K · Sold 29.7K
Granted 79.6K · Sold 20.2K
Granted 32.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Sutter Martin PDirector, 10% owner · 3 transactions | +0.7% | 13.14M | 89.2K | — | — |
| Bartholdson John A.Director, 10% owner · 7 transactions | +4.1% | 7.05M | 104.3K | 105.5K | — |
| Hawkins William ADirector · 3 transactions | +48.1% | 297.6K | 96.7K | — | — |
| Singleton Mark LeonardSVP & CFO · 24 transactions | +1354.4% | 183.0K | 252.9K | — | 59.1K |
| D'Adamio AnthonySVP & General Counsel · 24 transactions | +246.3% | 158.0K | 165.5K | — | 39.2K |
| Nohra Guy PDirector · 4 transactions | +425.2% | 148.9K | 89.2K | — | 10.0K |
| Stalnecker Susan MDirector · 3 transactions | +181.8% | 138.2K | 89.2K | — | — |
| Claypoole Robert EPresident and CEO, Director · 6 transactions | — | 135.9K | 221.0K | — | 28.8K |
| Neels Guido JDirector · 3 transactions | +314.6% | 117.5K | 89.2K | — | — |
| Ladone Mary KayDirector · 4 transactions | +448.8% | 111.3K | 91.0K | — | — |
| Beyer PatDirector · 4 transactions | +485.2% | 108.7K | 90.1K | — | — |
| McMurry-Heath MichelleDirector · 6 transactions | +343.6% | 77.3K | 89.6K | — | 29.7K |
| Church Katrina JSVP & Chief Compliance Officer · 24 transactions | +442.5% | 64.2K | 79.6K | — | 20.2K |
| Cowdy Philip G.Director · 1 transaction | +275.9% | 44.0K | 32.3K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -81.5K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.